Veeresa Gududuru

Discovery of 2-arylthiazolidine-4-carboxylic acid amides as a new class of cytotoxic agents for prostate cancer.

Duane D. Miller, J. Dalton, E. Hurh, 2005, Journal of medicinal chemistry.

SAR studies of 2-arylthiazolidine-4-carboxylic acid amides: a novel class of cytotoxic agents for prostate cancer.

Duane D. Miller, J. Dalton, E. Hurh, 2005, Bioorganic & medicinal chemistry letters.

Synthesis and biological evaluation of novel cytotoxic phospholipids for prostate cancer.

Duane D. Miller, J. Dalton, E. Hurh, 2004, Bioorganic & medicinal chemistry letters.

Identification of Darmstoff analogs as selective agonists and antagonists of lysophosphatidic acid receptors.

Duane D. Miller, Y. Fujiwara, D. Baker, 2006, Bioorganic & medicinal chemistry letters.

Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer.

Duane D. Miller, J. Dalton, E. Hurh, 2004, Bioorganic & medicinal chemistry letters.

Structure-activity relationship studies of arylthiazolidine amides as selective cytotoxic agents for melanoma.

Duane D. Miller, J. Dalton, Wei Li, 2007, Anticancer research.

The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury.

Duane D. Miller, M. Arsura, A. Parrill, 2007, Gastroenterology.

Efficient microwave enhanced synthesis of 4-thiazolidinones

Duane D. Miller, J. Dalton, Veeresa Gududuru, 2004 .

Development of an LC-MS/MS assay to determine plasma pharmacokinetics of the radioprotectant octadecenyl thiophosphate (OTP) in monkeys.

Duane D. Miller, Hari Kosanam, G. Tigyi, 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.